Association Between Diabetes Mellitus and All-Cause and Cardiovascular Mortality Among Individuals With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease

被引:11
作者
Wu, Weiti [1 ]
Xiang, Jingjing [2 ]
Chen, Xiaoye [3 ]
机构
[1] Taizhou Hosp, Dept Infect Dis, Taizhou, Zhejiang, Peoples R China
[2] Taizhou Hosp, Dept Emergency, Taizhou, Zhejiang, Peoples R China
[3] Taizhou Hosp, Dept Radiotherapy, Taizhou, Zhejiang, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2021年 / 12卷
关键词
non-alcoholic fatty liver disease; diabetes mellitus; NHANES; cardiovascular; mortality; HEPATIC INSULIN-RESISTANCE; NAFLD; RISK; PATHOGENESIS; MEN;
D O I
10.3389/fendo.2021.773342
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveThe influence of diabetes on mortality among patients with non-alcoholic fatty liver disease (NAFLD) in the general population has not been extensively studied. This study aimed to determine the relationship between diabetes and all-cause and cardiovascular mortality in patients with hepatic ultrasound-confirmed NAFLD using data from the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. MethodsData from 4,037 adult individuals with NAFLD from the NHANES III and mortality outcomes linked to National Death Index records through December 31, 2015, were included. Cox proportional hazards models were used to calculate the hazard ratio (HR) and corresponding 95% CI for mortality from all causes and cardiovascular disease after adjusting for multiple variables. ResultsAmong 4,037 subjects with NAFLD (55.9% female), 483 had diabetes at baseline. During a median follow-up of 22.1 years, 1,517 (11.5%) died, including 332 (8.22%) from cardiovascular causes. Diabetes was associated with increased all-cause (HR 3.02 [95% CI 2.67-3.41]) and cardiovascular (HR 3.36 [95% CI 2.61-4.32]) mortality in an unadjusted multivariable Cox regression model. The association remained statistically significant after adjusting for a range of potential confounders (HR 2.20 [95% CI 1.90-2.55] for all-cause mortality and HR 2.47 [95% CI 1.81-3.37] for cardiovascular mortality). An additional stratified analysis did not reveal significantly altered results. ConclusionDiabetes was associated with all-cause and cardiovascular mortality in patients with NAFLD. This link could be further characterized in future studies assessing the degree of glycemic control and its relationship with mortality in patients with diabetes and NAFLD.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Non-alcoholic fatty liver disease in diabetes mellitus patients on chronic hemodialysis - A case series addressing cardiovascular and mortality risks
    Stoica, Roxana Adriana
    Tribus, Laura Carina
    Marin, Raluca Ioana
    David, Tara
    Preda, Carmen Monica
    Bica, Ioana Cristina
    Serafinceanu, Cristian
    FRONTIERS IN CLINICAL DIABETES AND HEALTHCARE, 2023, 4
  • [32] Association between hemoglobin glycation index and non-alcoholic fatty liver disease in the patients with type 2 diabetes mellitus
    Wang, Meng
    Li, Shiwei
    Zhang, Xinxin
    Li, Xin
    Cui, Jingqiu
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (11) : 1303 - 1311
  • [33] Association of serum uric acid with all-cause and cardiovascular mortality among adults with nonalcoholic fatty liver disease
    Yang, Sisi
    Ye, Ziliang
    Liu, Mengyi
    Zhang, Yanjun
    Wu, Qimeng
    Zhou, Chun
    Zhang, Zhuxian
    He, Panpan
    Zhang, Yuanyuan
    Li, Huan
    Liu, Chengzhang
    Qin, Xianhui
    CLINICAL ENDOCRINOLOGY, 2023, 98 (01) : 49 - 58
  • [34] Association between hemoglobin glycation index and non-alcoholic fatty liver disease
    Xing, Yuling
    Zhen, Yunfeng
    Yang, Liqun
    Huo, Lijing
    Ma, Huijuan
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [35] Association between metabolically healthy obesity and non-alcoholic fatty liver disease
    Man, Sailimai
    Lv, Jun
    Yu, Canqing
    Deng, Yuhan
    Yin, Jianchun
    Wang, Bo
    Li, Liming
    Liu, Hui
    HEPATOLOGY INTERNATIONAL, 2022, 16 (06) : 1412 - 1423
  • [36] Dietary vitamin K intake associates with reduced all-cause mortality in non-alcoholic fatty liver disease patients
    Yu Huang
    Xianfeng Zhu
    Liang Han
    Hulan Hu
    Scientific Reports, 15 (1)
  • [37] Cognitive Performance in Individuals With Non-Alcoholic Fatty Liver Disease and/or Type 2 Diabetes Mellitus
    Weinstein, Ali A.
    de Avila, Leyla
    Paik, James
    Golabi, Pegah
    Escheik, Carey
    Gerber, Lynn
    Younossi, Zobair M.
    PSYCHOSOMATICS, 2018, 59 (06) : 567 - 574
  • [38] Association between updated cardiovascular health construct and risks of non-alcoholic fatty liver disease
    Huang, Jiaojiao
    Xin, Zhuojun
    Cao, Qiuyu
    He, Ruixin
    Hou, Tianzhichao
    Ding, Yi
    Lu, Jieli
    Wang, Tiange
    Zhao, Zhiyun
    Xu, Yu
    Wang, Weiqing
    Ning, Guang
    Xu, Min
    Wang, Long
    Li, Mian
    Bi, Yufang
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2024, 34 (02) : 317 - 325
  • [39] Analysis of the association between non-alcoholic fatty liver disease and mortality in United States adults
    Rong, Fen
    Mai, Yiyi
    Shou, Lujia
    Zhu, Xinya
    Li, Meiyue
    Zhu, Liuchen
    Sun, Xiuli
    Zhao, Xinhua
    FRONTIERS IN NUTRITION, 2024, 11
  • [40] Role of non-alcoholic fatty liver disease in the evolution of renal function in patients with diabetes mellitus
    Aubert, Lucia
    Sandino, Justo
    Gutierrez-Solis, Elena
    Garcia-Martin, Florencio
    Segura, Julian
    Porrini, Esteban
    Morales, Enrique
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (06) : 1125 - 1131